Precision Fermentation Firm Liberation Labs Secures $50.5M to Scale Production

Liberation Labs has secured a total of $50.5 million in funding, including $31.5 million in new funding and $19 million from insider bridge notes. Key investors in this round include NEOM Investment Fund, Galloway Limited, and Meach Cove Capital, among others. This investment will support the completion of Liberation Labs' first commercial-scale precision fermentation biomanufacturing facility in Richmond, Indiana, which is expected to be operational later this year.

The plant will have a 600,000-liter fermentation capacity and a fully dedicated downstream process, producing bio-based materials for various applications. With a total of $125.5 million in deployable capital, Liberation Labs is focused on leveraging precision fermentation technology to meet the growing demand for bio-based consumer products. The company has received financial support from various sources, including private investments, equipment financing, and a loan guarantee from the US Department of Agriculture, as well as a feasibility study grant from the US Department of Defense to potentially expand its manufacturing capacity further.